Chengyuan Tang

8.1k total citations · 5 hit papers
100 papers, 6.1k citations indexed

About

Chengyuan Tang is a scholar working on Nephrology, Molecular Biology and Epidemiology. According to data from OpenAlex, Chengyuan Tang has authored 100 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Nephrology, 39 papers in Molecular Biology and 28 papers in Epidemiology. Recurrent topics in Chengyuan Tang's work include Acute Kidney Injury Research (24 papers), Autophagy in Disease and Therapy (22 papers) and Chemotherapy-induced organ toxicity mitigation (14 papers). Chengyuan Tang is often cited by papers focused on Acute Kidney Injury Research (24 papers), Autophagy in Disease and Therapy (22 papers) and Chemotherapy-induced organ toxicity mitigation (14 papers). Chengyuan Tang collaborates with scholars based in China, United States and Taiwan. Chengyuan Tang's co-authors include Zheng Dong, Zhiwen Liu, Man J. Livingston, Juan Cai, Liyu He, Shaoqun Shu, Fuyou Liu, Guochun Chen, Xiao-Ming Yin and Lin Sun and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Chengyuan Tang

98 papers receiving 6.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1

2016 456 citations Li Xiao, Chengyuan Tang et al. Redox Biology profile →
Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis

2018 358 citations Chengyuan Tang, Ming Yang et al. Redox Biology profile →
Autophagy in kidney homeostasis and disease

2020 354 citations Chengyuan Tang, Zhiwen Liu et al. profile →
Mitochondrial quality control in kidney injury and repair

2020 333 citations Chengyuan Tang, Juan Cai et al. profile →
Cisplatin nephrotoxicity: new insights and therapeutic implications

2022 300 citations Chengyuan Tang, Zheng Dong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chengyuan Tang China	39	2.9k	1.8k	1.5k	925	643	100	6.1k
Keizo Kanasaki Japan	49	2.4k 0.8×	1.2k 0.6×	979 0.7×	282 0.3×	747 1.2×	143	6.6k
Li Xiao China	34	2.1k 0.7×	1.0k 0.6×	689 0.5×	286 0.3×	523 0.8×	169	4.4k
Shougang Zhuang United States	53	4.8k 1.7×	2.4k 1.3×	831 0.6×	857 0.9×	661 1.0×	213	9.0k
Hunjoo Ha South Korea	49	2.8k 1.0×	2.0k 1.1×	801 0.5×	519 0.6×	512 0.8×	167	7.8k
Songming Huang China	36	1.9k 0.7×	1.2k 0.7×	416 0.3×	545 0.6×	348 0.5×	183	4.3k
Toshiro Sugimoto Japan	41	2.1k 0.7×	1.5k 0.8×	784 0.5×	324 0.4×	360 0.6×	100	5.3k
Rick G. Schnellmann United States	32	2.2k 0.8×	1.1k 0.6×	535 0.4×	491 0.5×	326 0.5×	81	4.4k
Hirotaka Matsuo Japan	39	2.7k 1.0×	2.5k 1.4×	503 0.3×	1.1k 1.2×	321 0.5×	147	6.4k
Naohiko Anzai Japan	46	2.9k 1.0×	1.8k 1.0×	343 0.2×	803 0.9×	439 0.7×	213	6.8k
Zhanjun Jia China	35	2.0k 0.7×	1.0k 0.6×	426 0.3×	541 0.6×	397 0.6×	174	4.3k

Countries citing papers authored by Chengyuan Tang

Since Specialization

Citations

This map shows the geographic impact of Chengyuan Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyuan Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyuan Tang more than expected).

Fields of papers citing papers by Chengyuan Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyuan Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyuan Tang. The network helps show where Chengyuan Tang may publish in the future.

Co-authorship network of co-authors of Chengyuan Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyuan Tang. A scholar is included among the top collaborators of Chengyuan Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyuan Tang. Chengyuan Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeng, Dong, et al.. (2024). The Function of H2A Histone Variants and Their Roles in Diseases. Biomolecules. 14(8). 993–993. 3 indexed citations

Liu, Haiyang, Qian Chen, Lili Wan, et al.. (2024). Mechanistic study of celastrol-mediated inhibition of proinflammatory activation of macrophages in IgA nephropathy via down-regulating ECM1. International Journal of Biological Sciences. 20(14). 5731–5746. 7 indexed citations

Yang, Ming, et al.. (2024). ACSL5 promotes lipid deposition and lipoapoptosis in proximal tubular epithelial cells of diabetic kidney disease. Molecular and Cellular Endocrinology. 595. 112418–112418. 2 indexed citations

Liang, Peng, Di Liu, Chengyuan Tang, et al.. (2023). EIF2α/ATF4 pathway enhances proliferation of mesangial cell via cyclin D1 during endoplasmic reticulum stress in IgA nephropathy. Clinical Immunology. 257. 109840–109840.

Fu, Ying, et al.. (2023). Autophagy in acute kidney injury and maladaptive kidney repair. Burns & Trauma. 11. tkac059–tkac059. 17 indexed citations

Fu, Ying, et al.. (2022). Persistent Activation of Autophagy After Cisplatin Nephrotoxicity Promotes Renal Fibrosis and Chronic Kidney Disease. Frontiers in Pharmacology. 13. 918732–918732. 21 indexed citations

Peng, Liang, Di Liu, Haiyang Liu, et al.. (2022). Bombesin receptor-activated protein exacerbates cisplatin-induced AKI by regulating the degradation of SIRT2. Nephrology Dialysis Transplantation. 37(12). 2366–2385. 5 indexed citations

Xia, Ming, Di Liu, Haiyang Liu, et al.. (2022). Identification of Hub Genes and Therapeutic Agents for IgA Nephropathy Through Bioinformatics Analysis and Experimental Validation. Frontiers in Medicine. 9. 881322–881322. 5 indexed citations

Ju, Wei, Yi Shan, Xiao Zheng, et al.. (2022). Anp32e promotes renal interstitial fibrosis by upregulating the expression of fibrosis-related proteins. International Journal of Biological Sciences. 18(15). 5897–5912. 8 indexed citations

10.

Liu, Haiyang, et al.. (2021). Based on Network Pharmacology Tools to Investigate the Mechanism of Tripterygium wilfordii Against IgA Nephropathy. Frontiers in Medicine. 8. 794962–794962. 13 indexed citations

11.

Yin, Lijun, Honglin Li, Zhiwen Liu, et al.. (2021). PARK7 Protects Against Chronic Kidney Injury and Renal Fibrosis by Inducing SOD2 to Reduce Oxidative Stress. Frontiers in Immunology. 12. 690697–690697. 14 indexed citations

12.

Wang, Jiayi, Xiang Zhou, Yu Liu, et al.. (2020). Metabolomics window into the role of acute kidney injury after coronary artery bypass grafting in diabetic nephropathy progression. PeerJ. 8. e9111–e9111. 5 indexed citations

13.

Wang, Ying, Jiefu Zhu, Zhiwen Liu, et al.. (2020). The PINK1/PARK2/optineurin pathway of mitophagy is activated for protection in septic acute kidney injury. Redox Biology. 38. 101767–101767. 131 indexed citations

14.

Shu, Shaoqun, Ying Wang, Meiling Zheng, et al.. (2019). Hypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair. Cells. 8(3). 207–207. 192 indexed citations

15.

Liao, Yingjun, Chengyuan Tang, Xiao Zheng, et al.. (2019). RNA‐Seq analysis of potential lncRNAs and genes for the anti‐renal fibrotic effect of norcantharidin. Journal of Cellular Biochemistry. 120(10). 17354–17367. 15 indexed citations

16.

Xiang, Xiaohong, Chunyuan Guo, Chengyuan Tang, Juan Cai, & Zheng Dong. (2019). Epigenetic Regulation in Kidney Toxicity: Insights From Cisplatin Nephrotoxicity. Seminars in Nephrology. 39(2). 152–158. 27 indexed citations

17.

Tang, Chengyuan, Zhengwei Ma, Jiefu Zhu, et al.. (2018). P53 in kidney injury and repair: Mechanism and therapeutic potentials. Pharmacology & Therapeutics. 195. 5–12. 90 indexed citations

18.

Cheng, Wei, Fei Zhao, Chengyuan Tang, et al.. (2018). Comparison of iohexol and iodixanol induced nephrotoxicity, mitochondrial damage and mitophagy in a new contrast-induced acute kidney injury rat model. Archives of Toxicology. 92(7). 2245–2257. 52 indexed citations

19.

He, Liyu, Xiaofei Peng, Guoyong Liu, et al.. (2015). Anti-inflammatory effects of triptolide on IgA nephropathy in rats. Immunopharmacology and Immunotoxicology. 37(5). 421–427. 38 indexed citations

20.

Lin, Yunting, Chengyuan Tang, Hua He, & Ranhui Duan. (2013). Activation of mTOR Ameliorates Fragile X Premutation rCGG Repeat-Mediated Neurodegeneration. PLoS ONE. 8(4). e62572–e62572. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact